GILD
GILEAD SCIENCES, INC.F1915-min delayed · EOD close149.69 −1.11% downas of 2026-09-24mkt cap $186B
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000882095
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $31.0B | 2026-09-30 | 10-Q · 0000882095-26-000039 |
| Revenue (prior year) | $28.8B | 2024-12-31 | 10-K · 0000882095-25-000006 |
| Operating income | −$2.4B | 2026-09-30 | 10-Q · 0000882095-26-000039 |
| Net income | −$3.9B | 2026-09-30 | 10-Q · 0000882095-26-000039 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $51.4B | 2026-09-30 | 10-Q · 0000882095-26-000039 |
| Current assets | $16.6B | 2026-09-30 | 10-Q · 0000882095-26-000039 |
| Current liabilities | $12.0B | 2026-09-30 | 10-Q · 0000882095-26-000039 |